1-5 of 5
Authors: Samin K Sharma
Journal Article
Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 66–74, https://doi.org/10.1093/ehjcvp/pvae080
Published: 17 October 2024
Journal Article
Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registry
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 1, January 2024, Pages 11–19, https://doi.org/10.1093/ehjcvp/pvad069
Published: 23 September 2023
Journal Article
Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCI
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 8, December 2022, Pages 796–805, https://doi.org/10.1093/ehjcvp/pvac024
Published: 07 April 2022
Journal Article
Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 7, November 2022, Pages 707–716, https://doi.org/10.1093/ehjcvp/pvac016
Published: 23 March 2022
Journal Article
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 5, September 2022, Pages 492–502, https://doi.org/10.1093/ehjcvp/pvab068
Published: 30 August 2021
